Mario Schlosser Sells 600,000 Shares of Oscar Health (NYSE:OSCR) Stock

Oscar Health, Inc. (NYSE:OSCR) Director Mario Schlosser sold 600,000 shares of the company’s stock in a transaction on Thursday, August 27th. The stock was sold at an average price of $30.34, for a total value of $18,204,000.00. Following the sale, the director owned 480,866 shares of the company’s stock, valued at approximately $14,589,474.44. This represents a 55.51% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Mario Schlosser also recently made the following trade(s):

• On Friday, August 28th, Mario Schlosser sold 150,000 shares of Oscar Health stock. The shares were sold at an average price of $30.79, for a total value of $4,618,500.00.
• On Tuesday, June 23rd, Mario Schlosser sold 147,500 shares of Oscar Health stock. The stock was sold at an average price of $29.38, for a total value of $4,333,550.00.
• On Tuesday, June 23rd, Mario Schlosser sold 880,000 shares of Oscar Health stock. The stock was sold at an average price of $29.38, for a total value of $25,854,400.00.
• On Tuesday, June 2nd, Mario Schlosser sold 34,120 shares of Oscar Health stock. The stock was sold at an average price of $21.94, for a total value of $748,592.80.

Oscar Health Price Performance

Shares of OSCR stock opened at $29.84 on Wednesday. The stock’s 50-day moving average is $30.29 and its 200 day moving average is $22.36. Oscar Health, Inc. has a 1-year low of $10.69 and a 1-year high of $33.55. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.09 and a quick ratio of 1.09. The company has a market cap of $9.21 billion, a P/E ratio of 21.31, a PEG ratio of 0.62 and a beta of 2.37.

Oscar Health (NYSE:OSCR) last announced its earnings results on Thursday, August 6th. The company reported $1.10 EPS for the quarter, topping analysts’ consensus estimates of $0.40 by $0.70. The business had revenue of $4.88 billion during the quarter, compared to the consensus estimate of $4.73 billion. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. The firm’s revenue was up 70.4% on a year-over-year basis. During the same period in the previous year, the company posted ($0.89) earnings per share. Research analysts predict that Oscar Health, Inc. will post 1.54 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Oscar Health

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its position in Oscar Health by 2.7% during the 4th quarter. Vanguard Group Inc. now owns 20,701,250 shares of the company’s stock worth $297,477,000 after acquiring an additional 540,851 shares during the period. T. Rowe Price Investment Management Inc. increased its holdings in shares of Oscar Health by 11.0% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 9,217,816 shares of the company’s stock valued at $132,461,000 after purchasing an additional 910,320 shares during the period. California State Teachers Retirement System raised its stake in shares of Oscar Health by 3,214.2% in the second quarter. California State Teachers Retirement System now owns 7,803,043 shares of the company’s stock worth $222,543,000 after purchasing an additional 7,567,600 shares during the last quarter. Morgan Stanley raised its stake in shares of Oscar Health by 42.8% in the fourth quarter. Morgan Stanley now owns 6,814,046 shares of the company’s stock worth $97,918,000 after purchasing an additional 2,043,758 shares during the last quarter. Finally, Thrive Capital Management LLC raised its stake in shares of Oscar Health by 33.4% in the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock worth $85,258,000 after purchasing an additional 1,588,395 shares during the last quarter. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Wall Street Analyst Weigh In

OSCR has been the subject of several recent analyst reports. Wall Street Zen upgraded shares of Oscar Health from a “buy” rating to a “strong-buy” rating in a research note on Sunday, June 14th. UBS Group raised their target price on shares of Oscar Health from $20.00 to $26.00 and gave the company a “neutral” rating in a research note on Friday, August 7th. The Goldman Sachs Group reaffirmed a “neutral” rating and issued a $30.00 price target on shares of Oscar Health in a report on Tuesday, August 11th. Robert W. Baird set a $27.00 price target on Oscar Health in a research report on Friday, August 7th. Finally, Wells Fargo & Company increased their price objective on Oscar Health from $20.00 to $27.00 and gave the company an “equal weight” rating in a report on Thursday, August 13th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and eight have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $26.22.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.